RankingsPricing
  1. JP-listed companies
  2. Takeda Pharmaceutical Company Limited
  3. Financials
  4. Cash from operations

Takeda Pharmaceutical Company Limited【JP:4502】

Market cap
¥8.08T
P/E ratio
52.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 20251,057,182+47.58%
Mar 31, 2024716,344-26.69%
Mar 31, 2023977,156-13.00%
Mar 31, 20221,123,105+11.10%
Mar 31, 20211,010,931+50.94%
Mar 31, 2020669,752+103.89%
Mar 31, 2019328,479-13.07%
Mar 31, 2018377,854+44.57%
Mar 31, 2017261,363+925.31%
Mar 31, 201625,491-86.03%
Mar 31, 2015182,517+22.73%
Mar 31, 2014148,720-55.00%
Mar 31, 2013330,520

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)